Nēsos is developing a noninvasive wearable earbud and software platform that delivers electric field "e-mmunotherapy" to modulate brain pathways and treat rheumatoid arthritis without drugs. The company’s approach aims to use the brain’s electrical signaling to change immune responses and reduce chronic inflammation, avoiding pharmaceutical side effects. Nēsos completed a 30-patient clinical trial that showed a meaningful reduction in RA disease severity and is currently running three clinical studies across three indications. The startup is also researching earbud applications for neurological and psychiatric conditions. It plans to seek U.S. Food and Drug Administration approval as a medical device. Funding will primarily support continued clinical trials and further research into mechanism and impact on the brain.

Total raised

$17M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2020